The Atomwise platform unlocks the potential of challenging targets by opening up access to billions of compounds to help our partners discover novel, potent and selective compounds. Our team closely collaborates with our partners at every step of the drug discovery process from hit identification to lead optimization and candidate selection. Our partners benefit from the power of Atomwise’s AI technology to identify diverse hits among billions of compounds, to increase potency and selectivity of hit scaffolds, and to provide optionality and guidance during lead optimization.
Working with our partners to tackle the most challenging targets in disease.